Ooi M - Search Results

1

Extensive bone marrow capillary network masquerading as fungal hyphae in a patient with systemic lupus erythematosus.

Seet D, Lee SY, Ooi M, Seet JE, Cho J, Mak A. Seet D, et al. Among authors: ooi m. Arthritis Rheumatol. 2022 May;74(5):910-911. doi: 10.1002/art.42053. Epub 2022 Apr 5. Arthritis Rheumatol. 2022. PMID: 34927395 No abstract available.

2

Daratumumab-based induction therapy for multiple myeloma: A systematic review and meta-analysis.

Chong LL, Soon YY, Soekojo CY, Ooi M, Chng WJ, de Mel S. Chong LL, et al. Among authors: ooi m. Crit Rev Oncol Hematol. 2021 Mar;159:103211. doi: 10.1016/j.critrevonc.2020.103211. Epub 2020 Dec 30. Crit Rev Oncol Hematol. 2021. PMID: 33387628 Review.

3

Bacterial Infection Among Patients With Multiple Myeloma Treated With Bortezomib-based Induction Therapy: Real-World Experience in an Asian Cancer Center.

Soekojo CY, Low JZ, Oh J, Ooi M, De Mel S, Chng WJ. Soekojo CY, et al. Among authors: ooi m. Clin Lymphoma Myeloma Leuk. 2020 Apr;20(4):e165-e170. doi: 10.1016/j.clml.2019.12.024. Epub 2020 Jan 9. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32019731

4

Immunotherapy in Multiple Myeloma.

Soekojo CY, Ooi M, de Mel S, Chng WJ. Soekojo CY, et al. Among authors: ooi m. Cells. 2020 Mar 3;9(3):601. doi: 10.3390/cells9030601. Cells. 2020. PMID: 32138182 Free PMC article. Review.

5

Natural History and Prognostic Factors at First Relapse in Multiple Myeloma.

Wang C, Soekojo CY, Mel S, Ooi M, Chen Y, Goh AZK, Nagarajan C, Chng WJ. Wang C, et al. Among authors: ooi m. Cancers (Basel). 2020 Jul 2;12(7):1759. doi: 10.3390/cancers12071759. Cancers (Basel). 2020. PMID: 32630644 Free PMC article.

6

Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma.

Jia Y, Zhou J, Tan TK, Chung TH, Wong RWJ, Chooi JY, Lim JSL, Sanda T, Ooi M, De Mel S, Soekojo C, Chen Y, Zhang E, Cai Z, Shen P, Ruan J, Chng WJ. Jia Y, et al. Among authors: ooi m. Blood Cancer J. 2021 Feb 12;11(2):32. doi: 10.1038/s41408-021-00421-7. Blood Cancer J. 2021. PMID: 33579893 Free PMC article.

7

Immunoglobulin M Monoclonal Gammopathies of Clinical Significance.

Girard LP, Soekojo CY, Ooi M, Chng WJ, de Mel S. Girard LP, et al. Among authors: ooi m. Front Oncol. 2022 Jun 9;12:905484. doi: 10.3389/fonc.2022.905484. eCollection 2022. Front Oncol. 2022. PMID: 35756635 Free PMC article. Review.

8

Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis.

Teoh PJ, An O, Chung TH, Chooi JY, Toh SHM, Fan S, Wang W, Koh BTH, Fullwood MJ, Ooi MG, de Mel S, Soekojo CY, Chen L, Ng SB, Yang H, Chng WJ. Teoh PJ, et al. Among authors: ooi mg. Blood. 2018 Sep 20;132(12):1304-1317. doi: 10.1182/blood-2018-02-832576. Epub 2018 Jul 30. Blood. 2018. PMID: 30061158 Free article.

9

Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis.

Soekojo CY, Wang GM, Chen Y, Casan J, Wolyncewicz G, Lin A, Poon LM, de Mel S, Koh LP, Tan LK, Ooi MG, Nagarajan C, Liu Y, Lai YY, Huang XJ, Spencer A, Gopalakrishnan SK, Lu J, Chng WJ. Soekojo CY, et al. Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):e470-e477. doi: 10.1016/j.clml.2019.04.011. Epub 2019 Apr 28. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31171473

10

Immunoglobulin M Paraproteinaemias.

Girard LP, Soekojo CY, Ooi M, Poon LM, Chng WJ, de Mel S. Girard LP, et al. Among authors: ooi m. Cancers (Basel). 2020 Jun 25;12(6):1688. doi: 10.3390/cancers12061688. Cancers (Basel). 2020. PMID: 32630470 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page